ProShare Advisors
CNCE

ProShare Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

ProShare Advisors’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,344
Closed -$62K – 2425
2021
Q1 		$62K Buy
12,344
+1,062
+9% +$8.58K ﹤0.01% 2213
2020
Q4 		$143K Buy
+11,282
New +$129K ﹤0.01% 1932
2019
Q2 		– Sell
-10,307
Closed -$124K – 1667
2019
Q1 		$124K Buy
10,307
+136
+1% +$2K ﹤0.01% 1549
2018
Q4 		$128K Sell
10,171
-1,982
-16% -$27.4K ﹤0.01% 1443
2018
Q3 		$180K Sell
12,153
-482
-4% -$7.58K ﹤0.01% 1615
2018
Q2 		$213K Sell
12,635
-185
-1% -$3.59K ﹤0.01% 1580
2018
Q1 		$294K Sell
12,820
-2,111
-14% -$47K ﹤0.01% 1330
2017
Q4 		$386K Buy
+14,931
New +$301K ﹤0.01% 1259
2016
Q4 		– Sell
-15,648
Closed -$158K – 1758
2016
Q3 		$158K Sell
15,648
-2,910
-16% -$31.8K ﹤0.01% 1378
2016
Q2 		$208K Buy
18,558
+326
+2% +$4.15K ﹤0.01% 1400
2016
Q1 		$249K Sell
18,232
-1,766
-9% -$25.4K ﹤0.01% 1300
2015
Q4 		$379K Buy
19,998
+1,809
+10% +$39.3K ﹤0.01% 1174
2015
Q3 		$341K Sell
18,189
-1,107
-6% -$18.8K ﹤0.01% 1096
2015
Q2 		$287K Buy
19,296
+4,643
+32% +$70.7K ﹤0.01% 1323
2015
Q1 		$222K Buy
14,653
+2,609
+22% +$36.4K ﹤0.01% 1664
2014
Q4 		$160K Buy
+12,044
New +$156K ﹤0.01% 1782

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ProShare Advisors's CNCE Position: Q2 2021 in Review

ProShare Advisors sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 12,344 shares — an estimated $62K sold.

ProShare Advisors first reported a position in CNCE in Q4 2014 and held it in 16 quarters. The position peaked at $386K in Q4 2017. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

  • ProShare Advisors reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • ProShare Advisors sold 12,344 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $62K.
  • ProShare Advisors first reported a position in Concert Pharmaceuticals, Inc. in Q4 2014 and held it in 16 quarters.
  • ProShare Advisors's Concert Pharmaceuticals, Inc. position peaked at $386K in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.